| # | Drug | Count |
|---|---|---|
| 0 | BOSENTAN | 22 |
| 1 | SILDENAFIL CITRATE | 16 |
| 2 | SILDENAFIL | 15 |
| 3 | SILDENAFIL POWDER, | 12 |
| 4 | FUROSEMIDE | 8 |
| 5 | TREPROSTINIL | 5 |
| 6 | INDOMETHACIN | 4 |
| 7 | DIGOXIN | 3 |
| 8 | HYDROCHLOROTHIAZIDE | 3 |
| 9 | MACITENTAN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MILRINONE LACTATE | 1 | 0.0036 |
| 1 | BERACTANT | 1 | 0.0027 |
| 2 | BETHANECHOL CHLORIDE | 1 | 0.0018 |
| 3 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 4 | NITRIC OXIDE | 3 | 0.0006 |
| 5 | BOSENTAN | 22 | 0.0004 |
| 6 | PREDNISOLONE SODIUM PHOSPHATE | 1 | 0.0004 |
| 7 | SILDENAFIL POWDER, | 12 | 0.0003 |
| 8 | INDOMETHACIN | 4 | 0.0003 |
| 9 | DOPAMINE HYDROCHLORIDE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Phosphodiesterase 5 Inhibitor [EPC] | 15 |
| 1 | Loop Diuretic [EPC] | 9 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 6 |
| 3 | Prostacycline Vasodilator [EPC] | 6 |
| 4 | Endothelin Receptor Antagonist [EPC] | 5 |
| 5 | Thiazide Diuretic [EPC] | 4 |
| 6 | Cardiac Glycoside [EPC] | 3 |
| 7 | Opioid Agonist [EPC] | 3 |
| 8 | Vasodilator [EPC] | 3 |
| 9 | Aldosterone Antagonist [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Surfactant [EPC] | 1 | 0.0009 |
| 1 | Vasopressin V2 Receptor Antagonist [EPC] | 2 | 0.0001 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 15 | 0.0001 |
| 3 | Prostacyclin Receptor Agonist [EPC] | 2 | 0.0001 |
| 4 | Prostacycline Vasodilator [EPC] | 6 | 0.0000 |
| 5 | Cardiac Glycoside [EPC] | 3 | 0.0000 |
| 6 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 7 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 8 | Glycopeptide Antibacterial [EPC] | 2 | 0.0000 |
| 9 | Penem Antibacterial [EPC] | 1 | 0.0000 |